| abstract |
The invention relates to cryptophycin derivatives having the structure of the following general chemical formula: to a process for preparing a cryptophycin derivative, to a pharmaceutical composition containing a cryptophycin derivative and a pharmaceutically acceptable carrier and additionally an antineoplastic agent and the use of cryptophycin derivatives to inhibit the proliferation of a mammalian cell or to treat a neoplastic state. à |